Literature DB >> 7308479

An increase in calmodulin during growth of normal and cancerous liver in vivo.

J P MacManus, B M Braceland, R H Rixon, J F Whitfield, H P Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7308479     DOI： 10.1016/0014-5793(81)80480-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  10 in total

Review 1.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Free calcium and calmodulin levels in acinar carcinoma and normal acinar cells of rat pancreas.

Authors:  J L Chien; J R Warren
Journal:  Int J Pancreatol       Date:  1988-03

3.  The purification and complete amino acid sequence of the 9000-Mr Ca2+-binding protein from rat placenta. Identity with the vitamin D-dependent intestinal Ca2+-binding protein.

Authors:  J P MacManus; D C Watson; M Yaguchi
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

4.  Evidence for a calmodulin inhibitory substance(s) isolated from human meningiomas.

Authors:  S D Antle; A K Ho; U P Kalyan-Raman
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

5.  Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.

Authors:  J W Wei; R A Hickie; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Calmodulin content of rat mammary tissue and isolated cells during pregnancy and lactation.

Authors:  T L Riss; P J Bechtel; C R Baumrucker
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

7.  Calmodulin content in human central nervous system tumors.

Authors:  A J Bridges; A K Ho
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

8.  Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin.

Authors:  W N Hait; L Grais; C Benz; E C Cadman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer.

Authors:  T G Parmer; M D Ward; E J Yurkow; V H Vyas; T J Kearney; W N Hait
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

10.  Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice.

Authors:  Min Wu; Sahn-Ho Kim; Indrani Datta; Albert Levin; Gregory Dyson; Jing Li; Stephanie Kaypee; M Mahadeva Swamy; Nilesh Gupta; Ho Jeong Kwon; Mani Menon; Tapas K Kundu; G Prem-Veer Reddy
Journal:  Oncotarget       Date:  2015-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.